13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 38 holding rows worth $483,927,204.
- Accession
- 0001420506-26-000422
- Filer
- CIK 1617201
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 38 entries on the cover page, a total value of $483,927,204 stated on the cover page (in dollars after the unit check, H1), rows summing to $483,927,204 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 1,380,000 | $43,414,800 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,074,112 | $35,123,462 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 2,392,523 | $33,016,817 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 8,477,338 | $29,925,003 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,529,600 | $26,282,544 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 3,209,788 | $25,517,815 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 554,633 | $23,449,883 | dollars as filed | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 90,133 | $20,120,390 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 110,000 | $20,044,200 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 210,000 | $20,023,500 | dollars as filed | |
| CONCENTRA GROUP HOLDINGS PAR | 20603L102 | COMMON STOCK | 891,030 | $17,535,470 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 977,152 | $16,533,412 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,150,000 | $16,376,000 | dollars as filed | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 1,035,086 | $15,371,027 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 665,000 | $13,971,650 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 530,393 | $13,965,248 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 627,162 | $13,609,415 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 262,904 | $12,238,181 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 898,499 | $10,296,799 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 2,381,502 | $8,692,482 | dollars as filed | |
| LABCORP HOLDINGS INC COM SHS | 504922105 | Stock | 34,532 | $8,663,388 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 55,000 | $7,153,300 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 17,109 | $6,803,394 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 243,404 | $6,187,330 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 683,872 | $5,566,718 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 235,000 | $4,902,100 | dollars as filed | |
| CAREDX INC | 14167L103 | COM | 250,000 | $4,710,000 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 95,000 | $3,838,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 743,942 | $2,611,236 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 136,741 | $2,428,520 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 816,909 | $2,369,036 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 30,000 | $2,294,700 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 17,000 | $2,292,535 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 250,244 | $2,107,054 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 35,000 | $2,066,750 | dollars as filed | |
| TRUEBLUE INC | 89785X101 | COM | 442,554 | $2,013,621 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,555,744 | $1,898,008 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 442,600 | $513,416 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-000422 | this filing | 2026-02-13 | acceptance time not in the bulk data set |